These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21863889)

  • 1. 4-benzimidazolyl-3-phenylbutanoic acids as novel PIF-pocket-targeting allosteric inhibitors of protein kinase PKCζ.
    Fröhner W; Lopez-Garcia LA; Neimanis S; Weber N; Navratil J; Maurer F; Stroba A; Zhang H; Biondi RM; Engel M
    J Med Chem; 2011 Oct; 54(19):6714-23. PubMed ID: 21863889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric regulation of protein kinase PKCζ by the N-terminal C1 domain and small compounds to the PIF-pocket.
    Lopez-Garcia LA; Schulze JO; Fröhner W; Zhang H; Süss E; Weber N; Navratil J; Amon S; Hindie V; Zeuzem S; Jørgensen TJ; Alzari PM; Neimanis S; Engel M; Biondi RM
    Chem Biol; 2011 Nov; 18(11):1463-73. PubMed ID: 22118680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and optimization of 1,3,5-trisubstituted pyrazolines as potent and highly selective allosteric inhibitors of protein kinase C-ζ.
    Abdel-Halim M; Diesel B; Kiemer AK; Abadi AH; Hartmann RW; Engel M
    J Med Chem; 2014 Aug; 57(15):6513-30. PubMed ID: 25058929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of benzoazepin-2-one analogs as allosteric binders targeting the PIF pocket of PDK1.
    Wei L; Gao X; Warne R; Hao X; Bussiere D; Gu XJ; Uno T; Liu Y
    Bioorg Med Chem Lett; 2010 Jul; 20(13):3897-902. PubMed ID: 20627557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3,5-Diphenylpent-2-enoic acids as allosteric activators of the protein kinase PDK1: structure-activity relationships and thermodynamic characterization of binding as paradigms for PIF-binding pocket-targeting compounds.
    Stroba A; Schaeffer F; Hindie V; Lopez-Garcia L; Adrian I; Fröhner W; Hartmann RW; Biondi RM; Engel M
    J Med Chem; 2009 Aug; 52(15):4683-93. PubMed ID: 19606904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2-(3-Oxo-1,3-diphenylpropyl)malonic acids as potent allosteric ligands of the PIF pocket of phosphoinositide-dependent kinase-1: development and prodrug concept.
    Wilhelm A; Lopez-Garcia LA; Busschots K; Fröhner W; Maurer F; Boettcher S; Zhang H; Schulze JO; Biondi RM; Engel M
    J Med Chem; 2012 Nov; 55(22):9817-30. PubMed ID: 23106316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a fluorescent ATP analog to probe the allosteric conformational change in the active site of the protein kinase PDK1.
    Hindie V; Lopez-Garcia LA; Biondi RM
    Methods Mol Biol; 2012; 928():133-41. PubMed ID: 22956138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of regulation of the atypical protein kinase C by N-terminal domains and an allosteric small compound.
    Zhang H; Neimanis S; Lopez-Garcia LA; Arencibia JM; Amon S; Stroba A; Zeuzem S; Proschak E; Stark H; Bauer AF; Busschots K; Jørgensen TJ; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2014 Jun; 21(6):754-65. PubMed ID: 24836908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
    Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
    Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of allosteric PIF-pocket ligands for PDK1 using NMR-based fragment screening and 1H-15N TROSY experiments.
    Stockman BJ; Kothe M; Kohls D; Weibley L; Connolly BJ; Sheils AL; Cao Q; Cheng AC; Yang L; Kamath AV; Ding YH; Charlton ME
    Chem Biol Drug Des; 2009 Feb; 73(2):179-88. PubMed ID: 19207420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
    Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
    J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bidirectional Allosteric Communication between the ATP-Binding Site and the Regulatory PIF Pocket in PDK1 Protein Kinase.
    Schulze JO; Saladino G; Busschots K; Neimanis S; Süß E; Odadzic D; Zeuzem S; Hindie V; Herbrand AK; Lisa MN; Alzari PM; Gervasio FL; Biondi RM
    Cell Chem Biol; 2016 Oct; 23(10):1193-1205. PubMed ID: 27693059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
    Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p38 kinase mediates nitric oxide-induced apoptosis of chondrocytes through the inhibition of protein kinase C zeta by blocking autophosphorylation.
    Kim JS; Park ZY; Yoo YJ; Yu SS; Chun JS
    Cell Death Differ; 2005 Mar; 12(3):201-12. PubMed ID: 15665819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinases.
    Comess KM; Sun C; Abad-Zapatero C; Goedken ER; Gum RJ; Borhani DW; Argiriadi M; Groebe DR; Jia Y; Clampit JE; Haasch DL; Smith HT; Wang S; Song D; Coen ML; Cloutier TE; Tang H; Cheng X; Quinn C; Liu B; Xin Z; Liu G; Fry EH; Stoll V; Ng TI; Banach D; Marcotte D; Burns DJ; Calderwood DJ; Hajduk PJ
    ACS Chem Biol; 2011 Mar; 6(3):234-44. PubMed ID: 21090814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zeta isoform of protein kinase C prevents oxidant-induced nuclear factor-kappaB activation and I-kappaBalpha degradation: a fundamental mechanism for epidermal growth factor protection of the microtubule cytoskeleton and intestinal barrier integrity.
    Banan A; Fields JZ; Zhang LJ; Shaikh M; Farhadi A; Keshavarzian A
    J Pharmacol Exp Ther; 2003 Oct; 307(1):53-66. PubMed ID: 12893839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase.
    Traxler PM; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
    J Med Chem; 1996 Jun; 39(12):2285-92. PubMed ID: 8691423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Activation mechanisms of protein kinase Czeta and its cellular function].
    Xu SJ; Cong B
    Sheng Li Ke Xue Jin Zhan; 2005 Oct; 36(4):309-13. PubMed ID: 16408768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate-selective inhibition of protein kinase PDK1 by small compounds that bind to the PIF-pocket allosteric docking site.
    Busschots K; Lopez-Garcia LA; Lammi C; Stroba A; Zeuzem S; Piiper A; Alzari PM; Neimanis S; Arencibia JM; Engel M; Schulze JO; Biondi RM
    Chem Biol; 2012 Sep; 19(9):1152-63. PubMed ID: 22999883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological activity of isophthalic acid derivatives targeted to the C1 domain of protein kinase C.
    Boije af Gennäs G; Talman V; Aitio O; Ekokoski E; Finel M; Tuominen RK; Yli-Kauhaluoma J
    J Med Chem; 2009 Jul; 52(13):3969-81. PubMed ID: 19438240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.